In patients with degenerative lumbar spondylolisthesis, the addition of fusion to lumbar spinal decompression surgery appears to confer no additional beneficial effects at 12 months when compared with decompression alone, according to a study.
A total of 2,252 patients with lumbar degenerative spondylolisthesis and symptomatic back or leg pain lasting at least 3 months (mean age 66 years, 70 percent women) were included in the target trial emulation. Of these, 1,446 underwent decompression alone, and 806 had decompression with fusion. The unadjusted baseline Oswestry Disability Index (ODI) scores were 38.9 and 41.4, respectively.
At 12 months, the ODI score did not significantly differ between the two groups: decompression alone (22.3, 95 percent confidence interval [CI], 15.5‒29.1) vs decompression with fusion (20.0, 95 percent CI, 13.9‒26.2), with a mean difference of 2.2 (95 percent CI, ‒1.6 to 6.1).
Notably, exploratory analyses revealed a worse ODI score for decompression with fusion for men with BMI ≥30 kg/m2. No between-group difference was observed in reoperation risk at 12 months.
This cohort study using the target trial framework involved adults aged 18‒80 years with lumbar degenerative spondylolisthesis spinal decompression. Participants underwent lumbar spinal decompression surgery alone or with fusion.
ODI score and reoperation at 12 months were the primary outcomes. The investigators used linear regression models with inverse probability weighting to obtain estimates for decompression with fusion vs decompression alone for prespecified subgroups, including, age, sex, BMI, smoking, back pain intensity, and American Society of Anesthesiologists grade.
The study was limited by possible residual confounding, according to the investigators.